StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) bonds

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3025% above fair value
$1415.55−16.12 (-1.13%)

Close on Nov 17, 2026Market cap $1.33TP/E 45.9Yield 0.44%

Debt

Borrowings on the balance sheet, Sep 30, 2026

Total debt
$49.50B
$2.52B due within a year
Net debt
$44.62B
After $4.89B of cash
Implied interest rate
2.35%
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2024

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Eli Lilly's 10-Q for the period ended Sep 30, 2026

IssueMaturesCarrying value
Notes due 20262026$1.63B
Notes due 20272027$2.52B
Notes due 20282028$3.26B
Notes due 20292029$3.08B
Notes due 20302030$2.13B
Notes due 2031 - 20402031$11.58B
Notes due 2041 - 20502041$4.54B
Notes due 2051 - 20602051$8.28B
Notes due 2061 - 20702061$5.82B
August 2024 Issuance Date Debt–$5.00B
August 2025 Issuance Date Debt–$6.75B
February 2023 Issuance Date Debt–$4.00B
February 2024 Issuance Date Debt–$6.50B
February 2025 Issuance Date Debt–$6.50B
May 2026–$9.00B

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?